EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Efficacy of Mediterranean Diet vs. Low‐ FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial

Prashant Singh, Gregory Dean, Sofia Iram, Westley Peng, Samuel W Chey, Samara Rifkin, Christine Lothen-Kline, Jane Muir, Allen A Lee, Shanti Eswaran iD, William D Chey

Neurogastroenterology & Motility · 2025-10 · 37 (10)

DOI: 10.1111/nmo.70060 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 24.04.2025. Verfasst von Prashant Singh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Divsion of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, USA. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Diet, Mediterranean, Diet, Carbohydrate-Restricted. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mediterranean diet (MD) has been proposed as a dietary therapy for irritable bowel syndrome (IBS) but its efficacy remains unclear. We compared the efficacy of MD to a diet low in fermentable oligo‐, di‐, monosaccharides, and polyols (LFD).

Methods

In this pilot‐feasibility, randomized controlled trial (RCT), adult patients with diarrhea‐predominant IBS (IBS‐D) or mixed bowel pattern (IBS‐M) were randomized to MD versus LFD for 4 weeks. Meals were provided for both groups (ModifyHealth, GA). Daily variables included abdominal pain intensity (API) and bloating, while IBS symptom severity score (IBS‐SSS) and IBS adequate relief (IBS‐AR) were scored weekly. The primary endpoint was the proportion of patients with ≥ 30% decrease in API for ≥ 2/4 weeks.

Results

Of 26 randomized patients, 20 finished the study (10 per group). Seventy‐three percent of the MD group met the primary endpoint compared to 81.8% of the LFD group ( p = 1.0). Although not statistically significant, a numerically higher proportion of the LFD group reported adequate relief and met the responder endpoint for IBS‐SSS (50‐point reduction) compared to the MD group (54.6% vs. 27.3% for IBS‐AR and 81.8% vs. 45.5% for IBS‐SSS, p = 0.39 and 0.18, respectively). The LFD group also had a significantly greater reduction in IBS‐SSS score over the 4‐week treatment period compared to the MD group (−105.5 vs. −60, p = 0.02).

Conclusion

MD provides symptom relief in IBS‐D and IBS‐M; however, the magnitude of relief was higher with the LFD. Larger diet comparison studies in real‐world settings are needed before MD can be routinely recommended to IBS patients. Trial Registration: Clinicaltrials.gov : NCT05807919.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeDiet, MediterraneanDiet, Carbohydrate-RestrictedHumansFemaleMalePilot ProjectsAdultMiddle AgedTreatment OutcomeFODMAP Diet

Stichwörter der Autor:innen

bowel habitsdietary therapyelimination dietnutrition

Autor:innen und Institutionen

  • Divsion of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, USA.
  • Modify Health, Alpharetta, Georgia, USA.
  • Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia.

ORCID-Profile: Shanti Eswaran

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Singh, P., Dean, G., Iram, S., Peng, W., Chey, S. W., Rifkin, S., Lothen-Kline, C., Muir, J., Lee, A. A., Eswaran, S., & Chey, W. D. (2025). Efficacy of Mediterranean Diet vs. Low‐ FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial. Neurogastroenterology & Motility, 37(10). https://doi.org/10.1111/nmo.70060

Vancouver

Singh P, Dean G, Iram S, Peng W, Chey SW, Rifkin S, et al. Efficacy of Mediterranean Diet vs. Low‐ FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial. Neurogastroenterology & Motility. 2025;37(10). doi:10.1111/nmo.70060

BibTeX
@article{Singh2025,
  author = {Singh, Prashant and Dean, Gregory and Iram, Sofia and Peng, Westley and Chey, Samuel W and Rifkin, Samara and Lothen-Kline, Christine and Muir, Jane and Lee, Allen A and Eswaran, Shanti and Chey, William D},
  title = {Efficacy of Mediterranean Diet vs. Low‐ FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial},
  journal = {Neurogastroenterology & Motility},
  year = {2025},
  volume = {37},
  number = {10},
  doi = {10.1111/nmo.70060}
}
Kostenlos starten →